Michele Bellandi
Vorstandsvorsitzender bei Vertex Pharmaceuticals (France) SAS
Profil
Michele Bellandi is currently the Co-Chief Executive Officer at Vertex Pharmaceuticals (France) SAS since 2021 and Director at Vertex Pharmaceuticals (U.K.) Ltd.
since 2018.
He previously worked as the Chief Commercial Officer at Amryt Pharma Holdings Ltd.
Aktive Positionen von Michele Bellandi
| Unternehmen | Position | Beginn |
|---|---|---|
Vertex Pharmaceuticals (U.K.) Ltd.
 Vertex Pharmaceuticals (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2011, Vertex Pharmaceuticals (U.K.) Ltd. is a subsidiary of Vertex Pharmaceuticals, Inc. that engages in research and experimental development on natural science. The company is based in London, UK. | Direktor/Vorstandsmitglied | 15.10.2018 |
Vertex Pharmaceuticals (France) SAS
 Vertex Pharmaceuticals (France) SAS Pharmaceuticals: MajorHealth Technology Part of Vertex Pharmaceuticals, Inc., Vertex Pharmaceuticals (France) SAS develops and manufactures pharmaceutical products. The company is based in Paris, France. The CEOs are Michele Bellandi, Jonathan Oppenheim. The French company was founded in 2011. | Vorstandsvorsitzender | 11.06.2021 |
Ehemalige bekannte Positionen von Michele Bellandi
| Unternehmen | Position | Ende |
|---|---|---|
Amryt Pharma Holdings Ltd.
 Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 31.03.2017 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Vertex Pharmaceuticals (U.K.) Ltd.
Vertex Pharmaceuticals (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2011, Vertex Pharmaceuticals (U.K.) Ltd. is a subsidiary of Vertex Pharmaceuticals, Inc. that engages in research and experimental development on natural science. The company is based in London, UK. | Commercial Services |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Vertex Pharmaceuticals (France) SAS
Vertex Pharmaceuticals (France) SAS Pharmaceuticals: MajorHealth Technology Part of Vertex Pharmaceuticals, Inc., Vertex Pharmaceuticals (France) SAS develops and manufactures pharmaceutical products. The company is based in Paris, France. The CEOs are Michele Bellandi, Jonathan Oppenheim. The French company was founded in 2011. | Health Technology |
